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Fragile X Syndrome
Fragile X syndrome is the single most common
form of inherited mental retardation, and after Down’s
syndrome, the most common identified form of men-
tal retardation (1-3). It occurs in all ethnic groups.
Estimates of the frequency of the disorder, based
on cytogenetic testing, suggested a prevalence of one
in 1,250 males and one in 2,000 females, but more
recent studies based on direct detection of the mu-
tation indicate a more conservative figure of one in
5,000. Nevertheless, it is the most frequent cause
of inherited mental retardation. Affected individuals
suffer from moderate to severe mental retardation
and various degrees of autistic behavior. The clini-
cal features also include an elongated facial ap-
pearance, wide prominent ears and enlarged testi-
cles (macroorchidism) in adult male patients (4).
Individuals with the syndrome show neuropathological
abnormalities such as thin, elongated dendritic spines
and enlargement of the hippocampus, caudate nu-
cleus, lateral ventricle, and thalamus (5). Even height,
occipitofrontal circumference, and sometimes weight
are increased, especially before puberty. Therefore,
fragile X syndrome is sometimes considered to be
an ‘overgrowth syndrome’.
As the name implies, this syndrome is an X-linked
genetic disorder and is frequently associated with the
expression of a folate sensitive fragile site, or a gap
observed in metaphase stains of the X chromo-
somes of affected individuals. The fragile site has
been mapped to region Xq27.3 on the long arm of
the X chromosome (1-3). Using a positional cloning
strategy, the FMR1 gene was isolated and the mu-
tational basis of the syndrome was determined to
be the expansion of a trinucleotide repeat (CGG)n
present in the 5’ untranslated region of the identi-
fied gene (6-8). FMR 1 is the first cloned gene, which
has been liked to human intelligence. The inher-
itance of fragile X syndrome had puzzled geneti-
cists for some years for two unusual inheritance
patterns, which fail to conform to the laws of Mendel
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(1-3). First, the risk of having the disease increases
in successive generations of a family (the so-called
Sherman paradox or genetic anticipation). Second,
phenotypically normal males produce descendants
with the fragile X syndrome. We now know that the
unusual inheritance patterns are due to the trinucleotide
repeat expansion. While in normal individuals the
CGG repeat length is polymorphic, ranging from 5
to 50 copies with an average number of 30, unaffected
male carriers possess between 50 and 200 repeats
(premutation) : in nearly all cases of fragile X pa-
tients, there is a large expansion in the number of
the CGG repeats, to more than 200 copies, and some-
times to more than a thousand copies. Transmis-
sion of premutation alleles from males always results
in premutation-sized alleles in their daughters,
accounting for the lack of affected daughters of trans-
mitting males. When females contribute premutation
alleles to their offspring, increases in size prevail
over decreases. The tendency for premutation-sized
alleles to increase in length, coupledwith the escalating
risk of transmission to full mutation, provides a
molecular explanation for the Sherman paradox of
increasing penetrance. This finding has led to the
discovery of a new dynamic mutation mechanism,
the so called trinucleotide repeat expansion, which
is responsible for a number of human genetic
neurological disorders including Huntington’s disease
and spinocerebellar ataxia (9, 10). This CGG repeat
expansion is associated with abnormalDNAmethylation
of both a nearby CpG island and the repeat itself
(1-3). As a result, the FMR1 locus becomes silent
at the transcriptional level and, thus, no translation
occurs (11-13) (Figure 1). Although the timing and
molecular mechanisms of the CGG repeat expan-
sion and methylation on expanded CGG repeat are
under extensive study, we do not know much about
when and how CGG repeat instability and DNA
methylation occur.
It has become clear that fragile X syndrome results
from the lack of FMR1 expression. In other words,
the cause of fragile X syndrome is a loss-of-function
of FMR1. This has been confirmed by theDutch-Belgian
Consortium who generated transgenic mice models
by targeted disruption (knockout) of the mouse
Fmr1 gene (14, 15). The Fmr1 knockout mice show
enlarged testes, abnormal dendritic spine mor-
phology, impaired cognitive function and abnormal
behavior, similar to humans with fragile X. The de-
velopment of the Fmr1 knockout mice was a critical
advance in elucidating the pathological mechanisms
that lead to mental retardation and behavioral ab-
normalities in fragile X syndrome. This animal model
might also be useful for developing therapeutic
strategies. However, as yet, very little is known about
the physiological function of FMR1.
The FMR1 Gene
Although a strong sequence conservation between
fruitfly (16), Xenopus (17), chicken (18), mouse
(19) and human (7) FMR1 cDNAs suggest that it
may have a “housekeeping” role, its physiological
function remains a mystery. One clue as to the
function of the FMR1 protein comes from the iden-
tification in the protein sequence of motifs charac-
teristic of RNA-binding proteins. We and the other
group found that the protein contains an RGG box
and two KH domains (13, 20) (Figure 2a). The RGG
box is a region of 20 to 25 amino acids containing
several Arg-Gly-Gly tripeptide repeats and this motif
has been found in numerous RNA-binding proteins (21).
The KH domain was discovered on the basis of primary
sequence similarity between the pre-mRNA-binding
protein hnRNP K and other RNA associated proteins
such as ribosomal protein S3, bacterial antiterminator
protein NusA, and a yeast meiosis-specific alterna-
tive splicing factorMer-1 and, therefore, it was named
K homology domain or KH domain (22, 23). The
hallmark of the KH domain is a strongly conserved
tetrapeptide Gly-x-x-Gly (x is often a positively charged
Fig. 1. Fragile X syndrome is caused by the lack of transcription
due to the expansion of the CGG repeat located in the 5’ UTR
of the FMR1 gene. Fragile X syndrome results from a massive
trinucleotide repeat expansion. As a result of the repeat expansion,
abnormal methylation of both a nearby CpG island and the repeat
itself takes place, causing transcriptional silencing of FMR1.
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amino acid), which is flanked with regularly spaced
hydrophobic residues within a region of 60-80 amino
acids (23 and 24). Many other proteins that con-
tain KH domains, such as Gld-1, Hex3 and quaking
have been shown to have extremely important
roles in development. Two KH domains are located
in the middle of the FMR1 protein and an RGG box
lies downstream of the KH domains. The RNA-binding
domains in FMR1 appear to be functional because
FMR1 was demonstrated to directly bind RNA in
vitro with some degree of sequence specificity. We
demonstrated that the in vitro translated FMR1
protein can bind to poly(G) and poly(U), syn-
thetic RNA homopolymers in a salt resistance
manner (13). Ashley et al. provided evidence that
the FMR1 protein selectively binds to a subset of
brain-derived RNA, with approximately 4% by mass
of human fetal brain message specifically binding
FMR1 protein (20). These findings suggested that
FMR1 post-transcriptionally regulates expression
of downstream genes that are critical for normal
development of intelligence. Since fragile X syndrome
is often associated with overgrowth phenotypes, potential
target genes may also encode growth-regulatory pro-
teins, and regulation of these genes by FMR1 may
affect the control of cell proliferation. However, cellular
RNA targets of FMR1 have not yet been identified.
Identification of the RNA targets of FMR1 protein
will be an important step toward understanding how
the absence of a single protein results in the pleiotropic
phenotype observed in fragile X syndrome.
FMR1 Interacting Proteins
It appears clear that a better understanding of
the function of FMR1 also requires identification
of proteins with which FMR1 protein may interact.
To identify such interacting proteins, we used the
yeast two hybrid system and isolated two novel
cDNAs for proteins which specifically interact with
FMR1 (25). Surprisingly, these FMR1 interacting
genes are very similar in overall structure to FMR1;
they sharẽ60% sequence homology with FMR1
(Figure 2A). Therefore, the two genes were named
FXR1 and FXR2 (FXR for fragile X related genes).
The importance of these genes is reflected in the
conservation of gene sequence from Xenopus to
human. Given the high degree of sequence similarity
among these proteins, it is not surprising that both
FXR1 and FXR2 proteins are also capable of bind-
ing to poly(G) and poly(U) in vitro. We have also
demonstrated, by means of a co-immunoprecipitation
assay, that FMR1 protein can form heterodimers
with FXR1 and FXR2 proteins in living cells (25
and data not shown). Further characterization of
the interactions among the family members using
glutathione-S-transferase (GST) fusion proteins re-
veals that every family member can form dimers with
every other family member and with itself (25)
(Figure 2B). These findings clearly indicate that
the three proteins form a gene family of proteins
related by structure and most likely by function, as
they interact with each other. Whatever the out-
come of this interaction, FMR1 can no longer be
considered to function alone but likely has, in FXR1
and FXR2, partners to perform its normal func-
tion, which is presumably critical for the develop-
ment of intelligence. This interaction could be a
mechanism of functional autoregulation of this new
family of RNA-binding proteins. For example, FXR1
and FXR2 could modulate RNA binding specificity
and/or affinity through a direct interaction with FMR1.
It is also possible that the free FMR1 protein may
be poorly configured for binding to RNA in the ab-
sence of FXR proteins. There is precedence from
two other RNA-binding protein systems for a decisive
influence of the protein-protein interaction on the
RNA binding of the proteins. The signal recognition
particle (SRP) is made up of six proteins and one
Fig. 2. The FMR1 family. A, Graphical alignment of peptide
sequences for FMR1 and homologues FXR1 and FXR2. This
family of RNA-binding proteins contains two types of RNA-binding
motifs, namely RGG box and KH domain. Note the high simi-
larity through the KH domains. B, A model summarizing the
observed interactions among the FMR1, FXR1 and FXR2.
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RNA (7SL). Two RNA-binding SRP proteins, SRP9
and SRP14, bind 7SL RNA efficiently only when both
are present in a complex with each other (26). The
mammalian U2 snRNA-binding proteins, U2B” and
U2A’ also form a complex in the absence of RNA
(27). Neither of these proteins is capable on their
own of specific interaction with U2 RNA, although
U2B” binds RNA in a relatively non-specific manner
and U2A’ interacts weakly with double-stranded
RNA. Formation of the U2A’ : U2B” complex is thought
to alter the conformation of U2B” in a manner that
greatly enhances its specific binding to the U2 snRNA
element and also reduces its non-specific binding
to U1 snRNA, a different class of snRNA. Notably,
both U2B” and U2A’ proteins are very similar in
overall structure as is the case for the FMR1/FXR
family.
Protein-protein interactions are intrinsic to virtually
every cellular process. There are a large number of
transient protein-protein interactions, which in turn
control a large number of cellular processes. All modi-
fications of proteins necessarily involve such transient
protein-protein interactions. These include the inter-
actions of protein kinases, protein phosphatases,
glycosyl transferases, etc., with their substrate pro-
teins. Such protein-modifying enzymes encompass
a large number of protein-protein interactions in
the cell and regulate all manner of fundamental
processes such as cell growth, cell cycle and signal
transduction. We have demonstrated the interactions
among the FMR1 family members. This raises the
possibility that FMR1 might function in a complex
with FXR1, FXR2 or both. It is of interest to deter-
mine whether complex formation or function is
regulated by other factors, such as phosphorylation,
or potential interactions with other cellular compo-
nents. In particular, the question of what can abrogate
or dissociate the interactions among the FMR1 family
proteins may be as important as the originally iden-
tified interaction partners.
Given the strong overall similarity and similar
biological properties, this family of RNA-binding
proteins is likely to show partial overlap in their
function and these proteins might be functionally
redundant in some cellular processes. However, it
is already clear that FXR1 and FXR2 cannot fully
complement the lack of FMR1 function in the fragile
X patients, since expression of FXR1 and FXR2 does
not appear to be effected in fragile X patients (17,
25). Thus they may have both partially comple-
mentary functions and independent functions. It
can be anticipated that, as is the case for FMR1,
hitherto unknown genetic disorders caused by ab-
errant expression of the FXR genes exist. In con-
trast to FMR1, both FXR1 and FXR2 are encoded
by autosomal genes (3q28 and 17p13, respectively :
17, 25 and 28). To our knowledge, no human genetic
disorder genes including mental retardation genes
have been mapped in their regions of the genome.
Therefore, it can also be assumed that if FXR1 and
FXR2 have independent functions which are es-
sential during early development, most mutations
of human FXR1 and FXR2 would be early embry-
onic lethal. In either case, it is of great interest in
determining whether or not loss of the FXR1 or FXR2
function is linked to mental retardation and/or other
abnormalities.
Ribosomal Association of FMR1 Family
Proteins
In addition to the interaction between the family
members, we have demonstrated an association of
this family of RNA-binding proteins with ribosomes
(29). Simultaneously and independently, several
other groups also reported that FMR1 protein is
associated with ribosomes in an RNA-dependent
manner (30-33). Although initially the FMR1 pro-
tein was interpreted to be associated with the 60S
large ribosomal subunit based upon cofractionation,
the more recent findings showed that FMR1 protein
is associated with elongating polyribosomes via large
mRNP particles (31, 33). However, these findings do
not eliminate the possible interactions between FMR1
protein-mRNP particles and the 60S ribosomal subunit
in vivo during various stages of translation, because
FMR1 protein has been found to co-immunoprecipitate
with the 60S subunit. Based upon the RNA-binding
activity and the ribosomal association, a hypoth-
esis has been raised that the FMR1 and FXR pro-
teins may have roles in translation. There are at
least two possible scenarios about how these proteins
translationally regulate expression of their target
mRNAs (Figure 3). First, since these proteins are
RNA-binding proteins with some sequence specificity
and associate ribosomes as mRNA-protein (mRNP)
complex, FMR1 and FXR proteins act as chaperones
or selectors for recruiting specific mRNAs onto the
ribosomes. Second, since considerable amounts of
FMR1 and FXR proteins are found in soluble frac-
tions, the distribution of these proteins between
free and ribosome-associated states may give rise
to structural heterogeneity of ribosomes with regard
to their complement of these proteins, which, in
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turn, influences mRNA selection. The former scenario
envisions that these proteins have specific binding
sites on a class of mRNAs and regulate their trans-
lation through their binding. This is akin toDrosophila
morphogen bicoid (bcd). bcd directly binds to the
discrete target sequences within the 3’ untranslated
regions (UTR) of the homeodomain protein caudal
mRNA and regulates, (in this case, represses) the
translation of the mRNA (34). This class of RNA-binding
proteins includes C. elegans fem-3 binding factor
(35) and mammalian hnRNP K (36). The second model
is related to the E. coli ribosomal protein S2 (Eco
S2). Eco S2 is one of the few ribosomal proteins
that exchanges on and off the ribosome, which gives
rise to structural heterogeneity of ribosomes (37,
38). While ribosomes containing Eco S2 efficiently
translate mRNAs containing Shine-Dalgarno sequences
in the 5’ leader sequences probably by affecting
base-pairing between the leader sequences and the
16S rRNA, ribosomes lacking Eco S2 preferentially
translate such leaderless mRNAs that are normally
translated inefficiently. In eukaryotes, base-pairing
interactions between 18S rRNA andmRNA has been
implicated in cap-independent initiation. Therefore,
FMR1 family proteins could regulate translation of
a class of mRNAs without directly binding to them
in such a way that FMR1 family proteins mask
sites in rRNA needed for preferential translation of
a subset of mRNAs, and loss of the FMR1 protein
in fragile X patients unmasks or modifies the sites
and, thus, influences translation of the mRNAs. In
either case, to understand the mechanisms under-
lying the potential role of FMR1 and FXR proteins
in translation, it will be important to identify bio-
logically important genes that are translationally
regulated by the FMR1 and FXR proteins.
The Functions of FMR1 and FXR Proteins
The expectation is that FMR1 and FXR proteins,
being ribosome-associated and RNA-binding proteins
with some sequence specificity, have important roles
in the translation of some specific mRNAs. However,
little is known about the specific function of this new
family of RNA-binding proteins. A major problem
in elucidating the function of FMR1 family proteins
has been the inability to identify a downstream gene(s)
whose expression may be regulated by this family
of proteins. To some extent this is partly because
biochemical characterization of these proteins, such
as extensive cell fractionation, has only recently
begun, and partly because the probes for the indi-
vidual proteins have only recently been obtained.
Furthermore, since FMR1 is clearly not essential
for general translation, it is possible that the effect
of the lack of the FMR1 protein may be subtle in in
vitro assays that have been commonly used for study
of translation such as rabbit reticulocyte lysates. It
is also possible that there may be enough functional
redundancy between FMR1 and FXR proteins, so
that, in these in vitro assays, their function will be
observed only when two or all of the FMR1 and
FXR proteins are completely removed from the test
fractions. However, the situation is very different
in vivo, where a subtle difference in protein con-
centration often appears sufficient to distinguish
between on or off states of gene expression, as is
the case for morphogens in Drosophila (39). It is
also possible that FMR1 and FXR proteins have
an individual function that may be either similar or
distinct, but together they promote high fidelity for
some process such as those required for neuronal
development. As described above, several obser-
vations are, nevertheless, strongly suggestive of a
role for FMR1 and FXR proteins in translational
Fig. 3. Possible function of the FMR1 family in translation. A,
A ‘direct selector’ model for the role of FMR1/FXR proteins in
translation. In this model, FMR1 and FXR proteins act as chap-
erones or selectors for recruiting specific mRNAs onto the ri-
bosomes. B, A ‘indirect selector’ model. The distribution of
FMR1/FXR proteins between free and ribosome-associated states
may give rise to structural heterogeneity of ribosomes with regard
to their complement of these proteins, which, in turn, influ-
ences mRNA selection.
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regulation of gene expression. Identification of the
target genes of FMR1 family proteins should help
to clarify the function of this family and, thus, the
mechanisms leading to fragile X syndrome, and may
also suggest new approaches to developing thera-
peutic strategies for the syndrome.
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